Evidence map›Paper›PMID 40297516›Full record

ReviewGlobal health, epidemiology and genomics2025

Chandipura Virus Resurgence in India: Insights Into Diagnostic Tools, Antiviral Development, and Public Health Implications.

Adewunmi Akingbola, Abiodun Adegbesan, Kolade Adegoke, Joel Chuku, Olajide Ojo, Petra Mariaria, Uthman Alao, Raolat Adenike Salami, Michael Oladunjoye

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Global health, epidemiology and genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Adewunmi AkingbolaDepartment of Public Health and Primary Care, University of Cambridge, Old Schools, Trinity Lane, Cambridgeshire, Cambridge CB2 1TN, UK.ORCID https://orcid.org/0000-0001-7245-0340
Abiodun AdegbesanAfrican Cancer Institute, Department of Global Health, Stellenbosch University, Cape Town, South Africa.ORCID https://orcid.org/0000-0001-9478-5360
Kolade AdegokeFaculty of Clinical Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.ORCID https://orcid.org/0009-0006-1509-0274
Joel ChukuDepartment of Medicine, V. N. Karazin Kharkiv National University, Svobody Square, Kharkiv 61022, Ukraine.ORCID https://orcid.org/0009-0006-8685-0074
Olajide OjoUniversity of West England, Coldharbour Ln, Stoke Gifford, Bristol, UK.ORCID https://orcid.org/0009-0005-6794-0085
Petra MariariaDepartment of Public Health and Primary Care, University of Cambridge, Old Schools, Trinity Lane, Cambridgeshire, Cambridge CB2 1TN, UK.ORCID https://orcid.org/0009-0006-6322-4249
Uthman AlaoDepartment of Biomedical Laboratory Science, University of Ibadan, Ibadan, Nigeria.
Raolat Adenike SalamiAfe Babalola University, Ado-Ekiti, Ekiti State, Nigeria.ORCID https://orcid.org/0009-0004-1877-8205
Michael OladunjoyeDepartment of Community Health, Lagos State University College of Medicine, Ikeja, Lagos, Nigeria.ORCID https://orcid.org/0009-0001-1088-4992

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiviral AgentsCommunicable Diseases, EmergingRhabdoviridae InfectionsVesiculovirusAnimalsDisease OutbreaksHumansIndiaPublic HealthAntiviral AgentsantiviralsChandipura virusencephalitisPCRsandfliesvector-borne diseases

Identifiers

PMID40297516
PMCPMC12037235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.